NanoViricides
NNVC
#10132
Rank
โ‚ฌ19.01 M
Marketcap
1,06ย โ‚ฌ
Share price
0.82%
Change (1 day)
-25.59%
Change (1 year)

NanoViricides (NNVC) - Cash on Hand

Cash on Hand as of June 2025 : โ‚ฌ1.33 Million

According to NanoViricides's latest financial reports the company has โ‚ฌ1.33 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

NanoViricides - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30โ‚ฌ4.46 M-40.15%
2023-06-30โ‚ฌ7.46 M-44.38%
2022-06-30โ‚ฌ13.42 M-22.42%
2021-06-30โ‚ฌ17.3 M41.83%
2020-06-30โ‚ฌ12.2 M442.65%
2019-06-30โ‚ฌ2.24 M-62.84%
2018-06-30โ‚ฌ6.05 M-54.27%
2017-06-30โ‚ฌ13.23 M-39.18%
2016-06-30โ‚ฌ21.75 M-23.02%
2015-06-30โ‚ฌ28.26 M5.45%
2014-06-30โ‚ฌ26.79 M150.49%
2013-06-30โ‚ฌ10.69 M-5.13%
2012-06-30โ‚ฌ11.27 M77.24%
2011-06-30โ‚ฌ6.36 M14.41%
2010-06-30โ‚ฌ5.56 M365.48%
2009-06-30โ‚ฌ1.19 M130.45%
2008-06-30โ‚ฌ0.51 M-28%
2007-06-30โ‚ฌ0.72 M-63.62%
2006-06-30โ‚ฌ1.97 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.18 B 13,558.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚ฌ0.65 B 48,848.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ6.31 B 471,425.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ14.17 B 1,058,697.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ15.64 B 1,168,542.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ3.81 B 285,059.38%๐Ÿ‡ฌ๐Ÿ‡ง UK